1 Day
Source:
المشهد
Ozempic lowers sick leave
A Danish study that followed 7,011 Ozempic users found that their absence from work due to long-term sick leave was 17.3% lower in the four years after they began treatment, while government payments for sick-leave benefits fell by 19.4%. The researchers estimated annual savings of about 4,163 Danish kroner per employed patient—roughly $630. However, the study found no increase in employment or income and did not establish a direct cause for the decline. The researchers suggested it may have been linked to fewer emergency-room visits and prescriptions for cardiovascular medications. They cautioned that the findings do not establish long-term effects, since the study relied on health and tax records and was not a randomized trial.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)